Total Number of Shares and Voting Rights
On October 31, 2020
| Total number of outstanding shares |
Theoretical voting rights | Exercisable voting rights (minus treasury shares) |
| 78,317,810 | 78,317,810 | 78,012,771 |
Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.